Mitral Valve Screening Survey

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Medstar Health Research Institute
Study ID
NCT04736667
Status
Recruiting
Apply to this trial

Conditions

  • Mitral Valve Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).

Key Dates

Start date
Aug 6, 2021
Status verified
Aug 2025
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Subjects fail screening for TMVI
    Subjects with symptomatic mitral valve disease who after referral for TMVI, are deemed not to be candidates for TMVI.

Primary Outcome Measure

All-cause mortality [ Time Frame: 1 year ]

Central Contacts

Locations (14)

FacilityCityStateZIPSite coordinators
Phoenix Cardiovascular Research GroupPhoenixArizona85016
Jessica Byrne
[email protected]
Timothy Byrne, DO (PRINCIPAL_INVESTIGATOR)
Keck Hospital of USCLos AngelesCalifornia90033
Melody Nazar
[email protected]
Jose Escobar
[email protected]
Vaughn Starnes, MD (PRINCIPAL_INVESTIGATOR)
MedStar Washington Hospital CenterWashington D.C.District of Columbia20010
Erin Collins
[email protected]
Jake Sutton
[email protected]
202-877-6624
Ron Waksman, MD (PRINCIPAL_INVESTIGATOR)
Morton Plant HospitalClearwaterFlorida33756
John Menezes
[email protected]
Sue Fisher
[email protected]
Joshua Rovin, MD (PRINCIPAL_INVESTIGATOR)
HealthPark Medical CenterFort MyersFlorida33908
Michelle Deckard
[email protected]
Michael DeFrain, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Allison Mossell
[email protected]
Nicole Kappel
[email protected]
Christopher Malaisrie, MD (PRINCIPAL_INVESTIGATOR)
MercyOne Iowa Heart CenterWest Des MoinesIowa50266
Kendra Tuttle
[email protected]
Atul Chawla, MD (PRINCIPAL_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66103
Kartik Munshi
[email protected]
Tilitha Shawgo
[email protected]
Emmanuel Daon, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Ignacio Inglessis, MD (PRINCIPAL_INVESTIGATOR)
Ascension St. John's HospitalDetroitMichigan48236
Theodore Schreiber, MD (PRINCIPAL_INVESTIGATOR)
NYU Langone Health - Long IslandMineolaNew York11501
Alison DePaolis
[email protected]
Melissa Batteria
[email protected]
Richard Schwartz, DO (PRINCIPAL_INVESTIGATOR)
The Ohio State UniversityColumbusOhio43210
Annie Kellum
[email protected]
Kalyn Ferguson
[email protected]
Konstantinos Boudoulas, MD (PRINCIPAL_INVESTIGATOR)
Oregon Health Sciences UniversityPortlandOregon98239
Anna Garwood
[email protected]
Taylor Toro
[email protected]
Harsh Golwala, MD (PRINCIPAL_INVESTIGATOR)
Aurora St. Luke's Medical CenterMilwaukeeWisconsin53215
Denise Bailey
[email protected]
Tanvir Bajwa, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

By research site
Phoenix Cardiovascular Research Group· Phoenix, AZKeck Hospital of USC· Los Angeles, CAMedStar Washington Hospital Center· Washington D.C., DCMorton Plant Hospital· Clearwater, FLHealthPark Medical Center· Fort Myers, FLNorthwestern University· Chicago, IL

Related Studies